survival analysis

(redirected from Duration analysis)
Also found in: Wikipedia.

sur·viv·al a·nal·y·sis

a class of statistical procedures for estimating survival rates and making inferences about effects of treatment, prognostic factors, and other concerns.

survival analysis

Statistics Assessment of the amount of time that a person or population lives after a particular intervention or condition

survival analysis

An evaluation of how long patients in a clinical trial live. The rate of death is monitored over time.
Synonym: time-to-event analysis
References in periodicals archive ?
Mark Israel's dissertation topic was titled, "Firm Specific Demand for Auto Insurance: A Duration Analysis.
Risk measurement concepts such as Gap Analysis, Duration Analysis, Simulation
Our methodology allows the duration analysis to adjust for the "decay rate" of hitter skills.
My preference here goes to Chapter 12 on Duration Analysis.
A measure of interest rate risk under consideration for use in the screening process applies the principles of duration analysis to the familiar maturity gap report.
Aberdeen primarily uses F3 for the valuation and duration analysis of various rate and credit based swap instruments, but plans on expanding its use of F3 to perform Monte Carlo simulations of its portfolios and various forms of scenario analysis.
Duration analysis also represents a form of dynamic hedging.
Key Rate Duration analysis, now available at the sector level, will help managers more effectively gauge sensitivity to non-parallel shifts in the credit curve.
Several sophisticated techniques are used to evaluate the firm's exposure to interest rate risk and policy surrenders, such as cash flow modeling and option adjusted duration analysis.
0 also adds support for Latin American Spanish, call duration analysis, custom SMART rules development, interactive query and reporting client, an enhanced call audio player, and many administration improvements.
Additionally, a duration analysis allows one to examine the temporal dimension of policy adoption that is not captured by the cross-section analysis.
Pharmaceutical Development Phases: a Duration Analysis.